Roman Pfister
University of Cologne
278 Papers
405 Citations
Roman Pfister is an academic researcher from University of Cologne. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 236 publications. Previous affiliations of Roman Pfister include University of Cambridge & Medical Research Council.
Chat about Author
Papers
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy
Christian Templin,Jelena R. Ghadri,Johanna Diekmann,L. Christian Napp,Dana Roxana Bataiosu,Milosz Jaguszewski,Victoria L. Cammann,Annahita Sarcon,Verena Geyer,Catharina A. Neumann,Burkhardt Seifert,Jens P. Hellermann,Moritz Schwyzer,Katharina Eisenhardt,Josef Jenewein,Jennifer Franke,Hugo A. Katus,Christof Burgdorf,Heribert Schunkert,Christian Moeller,Holger Thiele,Johann Bauersachs,Carsten Tschöpe,Heinz-Peter Schultheiss,Charles A. Laney,Lawrence Rajan,Guido Michels,Roman Pfister,Christian Ukena,Michael Böhm,Raimund Erbel,Alessandro Cuneo,Karl-Heinz Kuck,Claudius Jacobshagen,Gerd Hasenfuss,M. Karakas,M. Karakas,Wolfgang Koenig,Wolfgang Koenig,Wolfgang Rottbauer,Samir M. Said,Ruediger C. Braun-Dullaeus,Florim Cuculi,Adrian P. Banning,Thomas Fischer,Tuija Vasankari,K.E. Juhani Airaksinen,Marcin Fijałkowski,Andrzej Rynkiewicz,Maciej Pawlak,Grzegorz Opolski,Rafal Dworakowski,Philip MacCarthy,Christoph Kaiser,Stefan Osswald,Leonarda Galiuto,Filippo Crea,Wolfgang Dichtl,Wolfgang-Michael Franz,Klaus Empen,Stephan B. Felix,Clément Delmas,Olivier Lairez,Paul Erne,Jeroen J. Bax,Ian Ford,Frank Ruschitzka,Abhiram Prasad,Thomas F. Lüscher +68 more
TL;DR: Patients with takotsubo cardiomyopathy had a higher prevalence of neurologic or psychiatric disorders than did those with an acute coronary syndrome and physical triggers, acute neurologics or psychiatric diseases, high troponin levels, and a low ejection fraction on admission were independent predictors for in-hospital complications.
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides
TL;DR: In the current ESC guidelines for the management of heart failure, B-type natriuretic peptides are integrated for the first time into a concrete diagnostic algorithm for patients with suspected first presentation of chronic heart failure.
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
Daniel I. Swerdlow,Michael V. Holmes,Karoline Kuchenbaecker,Engmann Jel.,Tina Shah,Reecha Sofat,Yiran Guo,C Chung,Anne Peasey,Roman Pfister,Simon P. Mooijaart,Helen Ireland,Maarten Leusink,Claudia Langenberg,KaWah Li,Jutta Palmen,Phil Howard,Jackie A. Cooper,Fotios Drenos,John Hardy,Mike A. Nalls,Yun Li,Gordon D.O. Lowe,Marlene C. W. Stewart,S. J. Bielinski,Julian Peto,Nicholas J. Timpson,John Gallacher,Malcolm G. Dunlop,Richard S. Houlston,Ian Tomlinson,Ioanna Tzoulaki,Jian'an Luan,Boer Jma.,Nita G. Forouhi,N. C. Onland-Moret,Y. T. van der Schouw,Renate B. Schnabel,Jaroslav A. Hubacek,Růžena Kubínová,Migle Baceviciene,Abdonas Tamosiunas,Andrzej Pajak,Roman Topor-Madry,Sofia Malyutina,Damiano Baldassarre,Bengt Sennblad,Elena Tremoli,U de Faire,Luigi Ferrucci,S Bandenelli,Tetsu Tanaka,James F. Meschia,AB Singleton,Gerjan Navis,I. Mateo Leach,Bakker Sjl.,Ron T. Gansevoort,Ian Ford,Stephen E. Epstein,Mary-Susan Burnett,Joe Devaney,Johan Wouter Jukema,Westendorp Rgj.,G Jan de Borst,Y. van der Graaf,P A de Jong,Mailand-van der Zee A-H.,Olaf H. Klungel,A. de Boer,P. A. Doevendans,Jeffrey W. Stephens,Charles B. Eaton,Jennifer G. Robinson,JoAnn E. Manson,F G Fowkes,Timothy M. Frayling,Jenna Price,Peter H. Whincup,Richard W Morris,Debbie A Lawlor,George Davey Smith,Yoav Ben-Shlomo,Susan Redline,Leslie A. Lange,Meena Kumari,Nicholas J. Wareham,Verschuren Wmm.,Emelia J. Benjamin,John C. Whittaker,Anders Hamsten,Frank Dudbridge,Delaney Jac.,Andrew Wong,Diana Kuh,Rebecca Hardy,Berta Almoguera Castillo,John Connolly,P. van der Harst,Eric J. Brunner,Michael Marmot,Christina L. Wassel,Steve E. Humphries,P.J. Talmud,Mika Kivimäki,Folkert W. Asselbergs,Mikhail I. Voevoda,Martin Bobak,Hynek Pikhart,James G. Wilson,Hakon Hakonarson,Alexander P. Reiner,Brendan J. Keating,Naveed Sattar,Aroon D. Hingorani,Juan P. Casas +115 more
TL;DR: IL6R blockade could provide a novel therapeutic approach to prevention of coronary heart disease that warrants testing in suitably powered randomised trials and could help to validate and prioritise novel drug targets or to repurpose existing agents and targets for new therapeutic uses.
1.1K
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study.
Denise Hilfiker-Kleiner,Arash Haghikia,Arash Haghikia,Dominik Berliner,Jens Vogel-Claussen,Johannes Schwab,Annegret Franke,Marziel Schwarzkopf,Philipp Ehlermann,Roman Pfister,Guido Michels,Ralf Westenfeld,Verena Stangl,Ingrid Kindermann,Uwe Kühl,Christiane E. Angermann,Axel Schlitt,Dieter Fischer,Edith Podewski,Michael Böhm,Karen Sliwa,Johann Bauersachs +21 more
TL;DR: Bromocriptine treatment was associated with high rate of full LV-recovery and low morbidity and mortality in P PCM patients compared with other PPCM cohorts not treated with bromocripine.
Long-Term Prognosis of Patients With Takotsubo Syndrome
Jelena-R. Ghadri,Ken Kato,Victoria L. Cammann,Sebastiano Gili,Stjepan Jurisic,Davide Di Vece,Alessandro Candreva,Katharina J. Ding,Jozef Micek,Konrad A. Szawan,Beatrice Bacchi,Rahel Bianchi,Rena A. Levinson,Manfred Wischnewsky,Burkhardt Seifert,Susanne A. Schlossbauer,Rodolfo Citro,Eduardo Bossone,Thomas Münzel,Maike Knorr,Susanne Heiner,Fabrizio D'Ascenzo,Jennifer Franke,Annahita Sarcon,L. Christian Napp,Miłosz Jaguszewski,Michel Noutsias,Hugo A. Katus,Christof Burgdorf,Heribert Schunkert,Holger Thiele,Johann Bauersachs,Carsten Tschöpe,Burkert Pieske,Lawrence Rajan,Guido Michels,Roman Pfister,Alessandro Cuneo,Claudius Jacobshagen,Gerd Hasenfuß,Mahir Karakas,Wolfgang Koenig,Wolfgang Rottbauer,Samir M. Said,Ruediger C. Braun-Dullaeus,Adrian P. Banning,Florim Cuculi,Richard Kobza,Thomas Fischer,Tuija Vasankari,K.E. Juhani Airaksinen,Grzegorz Opolski,Rafal Dworakowski,Philip MacCarthy,Christoph Kaiser,Stefan Osswald,Leonarda Galiuto,Filippo Crea,Wolfgang Dichtl,Klaus Empen,Stephan B. Felix,Clément Delmas,Olivier Lairez,Ibrahim El-Battrawy,Ibrahim Akin,Martin Borggrefe,John D. Horowitz,Martin Kozel,Petr Tousek,Petr Widimský,Ekaterina Gilyarova,Alexandra Shilova,Mikhail Gilyarov,David E. Winchester,Christian Ukena,Jeroen J. Bax,Abhiram Prasad,Michael Böhm,Thomas F. Lüscher,Frank Ruschitzka,Christian Templin +80 more
TL;DR: It is demonstrated that TTS can either be benign or a life-threating condition depending on the inciting stress factor, and a new classification based on triggers is proposed, which can serve as a clinical tool to predict short- and long-term outcomes of TTS.
283